Market Place
Sourcing Support
Enzychem Lifesciences Announces Poster Presentation of EC-18 at RRS 2022
25 Jul 2022 //
BUSINESSWIRE
Enzychem Lifesciences Announces Acceptance of EC-18 Abstract at MASCC/ISOO
12 Apr 2022 //
BUSINESSWIRE
Enzychem Lifesciences Announces Poster Presentation of EC-18 Abstract at ASCO
06 Apr 2022 //
BUSINESSWIRE
Enzychem Completes CSR for Phase 2 Study of EC-18 in Chemoradiation-Induced OM
09 Mar 2022 //
BUSINESSWIRE
Enzychem Lifesciences Announces Formation of Corporate Advisory Committee
02 Mar 2022 //
BUSINESSWIRE
PharmaJet partner Zydus Cadila Announces COVID-19 Vaccine Expansion Plan
04 Jan 2022 //
BUSINESSWIRE
Enzychem and Cadila collaborate to produce Covid-19 vaccine in Korea
29 Nov 2021 //
PHARMACEUTICAL-TECHNOLOGY
Cadila Healthcare enters pact with Korean Enzychem for DNA Covid-19 vaccine
24 Nov 2021 //
LIVEMINT
South Korea`s Enzychem to make Indian drugmaker Cadila`s COVID-19 shot
24 Nov 2021 //
REUTERS
Enzychem’s EC-18 reduces occurrence of oral mucositis in Phase II trial
20 Oct 2021 //
CLINICALTRIALSARENA
Enzychem Lifesciences Announces Positive Results for Phase 2 U.S. Study of EC-18
20 Oct 2021 //
BUSINESSWIRE
Enzychem Announces Database Lock for PII of EC-18 in CRIOM
13 Sep 2021 //
BUSINESSWIRE
Enzychem Lifesciences Selected to Collaborate with NIAID CCRP on the CERF
20 Apr 2021 //
PRNEWSWIRE
Enzychem Lifesciences Announces Oral Presentation of TLR Signaling Inhibition
16 Apr 2021 //
PRNEWSWIRE
Enzychem Lifesciences Announces Last Patient Enrolled in Stage 2 of Phase 2
06 Apr 2021 //
PRNEWSWIRE
Enzychem to Present at the 2021 NASH-TAG Conference Highlighting TLR
01 Mar 2021 //
PRNEWSWIRE
Enzychem Receives NASA Grant Funding to Evaluate EC-18 as a Protective Agen
26 Jan 2021 //
PRNEWSWIRE
Enzychem Lifesciences Presenting at Biotech Showcase Digital 2021
08 Jan 2021 //
PRNEWSWIRE
ENZYCHEM LIFESCIENCES ANNOUNCES FDA ACCEPTANCE OF PHASE 2 STUDY OF EC-18
13 Aug 2020 //
PRESS RELEASE
FDA accepts Enzychem’s application for Covid-19 trial
13 Aug 2020 //
CLINICALTRIALSARENA
Enzychem Lifesciences Announces FDA Acceptance of Phase 2 Study of EC-18
12 Aug 2020 //
BUSINESSWIRE
Enzychem submits IND for trial of Covid-19 treatment candidate
13 Jul 2020 //
CLINICALTRIALSARENA
Enzychem submits IND for trial of Covid-19 treatment candidate
13 Jul 2020 //
CLINICALTRIALSARENA
Enzychem Lifesciences Files IND Application to FDA for Phase 2 Study of EC-18
13 Jul 2020 //
PRNEWSWIRE
Enzychem Lifesciences Appoints Duke Medical Coronavirus Task Force Expert
18 May 2020 //
PRNEWSWIRE
Enzychem Lifesciences gets Korean nod to begin phase 2 study for EC-18
15 May 2020 //
PHARMABIZ
Enzychem Lifesciences Initiates Phase 2 Study for EC-18 in Preventing (ARDS
14 May 2020 //
PRNEWSWIRE
Enzychem Announces Publication of Preclinical Study of EC-18 in Gouty Arthritis
01 May 2020 //
PRNEWSWIRE
Enzychem Lifesciences Announces Plans to Advance Clinical Trial
17 Mar 2020 //
YAHOO
Anthem Issues Updates Regarding COVID-19 Testing
17 Mar 2020 //
BUSINESSWIRE
Enzychem Lifesciences announces collaborative Material Transfer Agreement
06 Dec 2019 //
PR NEWSWIRE
Enzychem Lifesciences Completes Successful Investor Roadshow in HK and Singapore
06 Sep 2018 //
PR NEWSWIRE
Enzychem Lifesciences held Launch Ceremony in USA
29 Jun 2018 //
PR NEWSWIRE
